Koyfin Home > Directory > Health Care > Amneal Pharmaceuticals Inc > Long-Term Debt / Capital

Amneal Pharmaceuticals Inc Long-Term Debt / Capital Chart (AMRX)

Amneal Pharmaceuticals Inc annual/quarterly Long-Term Debt / Capital from 2016 to 2018.
  • Amneal Pharmaceuticals Inc Long-Term Debt / Capital for the quarter ending December 12, 2018 was $74m a -68.13% decrease of -51m year over year
  • Amneal Pharmaceuticals Inc Long-Term Debt / Capital for the last 12 months ending December 12, 2018 was $74m a -68.13% decrease of -51m year over year
  • Amneal Pharmaceuticals Inc Annual Long-Term Debt / Capital for 2018 was $74m a -69.01% decrease of -51m from 2017
  • Amneal Pharmaceuticals Inc Annual Long-Term Debt / Capital for 2017 was $126m a 9.67% increase of 12m from 2016
  • Amneal Pharmaceuticals Inc Annual Long-Term Debt / Capital for 2016 was $114m a -1.59% decrease of -2m from 2015
Other Ratios Metrics:
  • Amneal Pharmaceuticals Inc Total Debt / Capital for the quarter ending December 12, 2018 was $75m a -77.49% decrease of -58m year over year
  • Amneal Pharmaceuticals Inc Other Liabilities for the quarter ending December 12, 2018 was $233m a 90.39% increase of 210m year over year
  • Amneal Pharmaceuticals Inc Total Debt / Equity for the quarter ending December 12, 2018 was $300m
View Chart On Koyfin

Quarterly AMRX Long-Term Debt / Capital Data

12/2018$74m
09/2018$71m
06/2018$72m
03/2018$125m
12/2017$126m
09/2017$135m
12/2016$114m

Annual AMRX Long-Term Debt / Capital Data

2018$74m
2017$126m
2016$114m
2015$115m